v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 476,845 $ 455,731
Marketable securities 360,185 364,645
Accounts receivable, net 63,094 63,009
Prepaid expenses and other current assets 41,697 41,033
Inventory, net 6,804 5,446
Total current assets 948,625 929,864
Property and equipment, net 9,770 10,092
Operating lease right of use assets, net 38,126 37,643
Deferred tax assets, net 14,355 14,790
Other non-current assets 17,132 17,117
Total assets 1,028,008 1,009,506
Current liabilities    
Accounts payable 29,105 25,100
Accrued expenses and other current liabilities 118,341 185,534
Operating lease liabilities, current 1,717 1,547
Total current liabilities 149,163 212,181
Accrued expenses, non-current 62,476 0
Deferred revenue, non-current 5,612 5,434
Operating lease liabilities, non-current 40,748 40,162
Interest-bearing loans and borrowings 391,530 391,013
Total liabilities 649,529 648,790
Commitments and contingencies (Note 10)
Shareholders’ equity    
Ordinary shares (voting and non-voting), £0.002 par value, most recent authority to allot up to a maximum nominal value of £97,234 and £97,454 shares as of March 31, 2025 and December 31, 2024, respectively, and 50,184,609 and 50,064,860 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively. 135 135
Deferred shares, £0.0001 par value, 5,793,501 shares authorized, issued and outstanding as of March 31, 2025 and December 31, 2024. 1 1
Additional paid-in capital 1,202,171 1,190,104
Accumulated deficit (790,738) (795,761)
Accumulated other comprehensive loss (33,090) (33,763)
Total shareholders' equity 378,479 360,716
Total liabilities and shareholders' equity $ 1,028,008 $ 1,009,506
Common stock, shares outstanding (in shares) 50,184,609 50,064,860
Common stock, shares issued (in shares) 50,184,609 50,064,860